Replicor to Participate in the Jefferies Hepatitis B Summit in Boston

[sorte]

Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B (HBV) and hepatitis D (HDV) infection, today announced that it will be participating in the Jefferies Hepatitis B summit to be held August 6, 2015 in Boston. This summit brings together companies developing state of the art antiviral technologies targeting HBV and thought leaders to discuss the future of treatment for chronic HBV infection.

Replicor will present an up-to-date overview of its clinical development program for its nucleic acid polymer (NAP) technology and the potential for achieving high rates of SVR in patients with chronic HBV infection and HBV / HDV co-infection.

http://www.businesswire.com/news/home/20150728005248/en/Replicor-Participate-Jefferies-Hepatitis-Summit-Boston#.Vbd4lrdRgn8

[Royal36]

Does this mean we have to expect some more advanced  and further clinical trial from the Bloomberg institute than the Arbutus in preclinical trial?

[sorte]

Another company which gonna present there, Arbutus is renamed Tekmira.

http://globenewswire.com/news-release/2015/08/03/757093/10144190/en/Arbutus-to-Present-at-Jefferies-Hepatitis-B-Summit.html

Arbutus Biopharma Corporation (NASDAQ:ABUS), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), today announced that Dr. Mark J. Murray, Tekmira's President and CEO, will present at the Jefferies Hepatitis B Summit on Thursday, August 6, 2015 at 7.45am – 8.15am (PT) / 10.45am – 11.15am (ET) in Boston. - See more at: http://globenewswire.com/news-release/2015/08/03/757093/10144190/en/Arbutus-to-Present-at-Jefferies-Hepatitis-B-Summit.html#sthash.O2DrsMVZ.dpuf

They have big hbv portfolio, not sure which ones are promising, comments appreciated:

http://www.arbutusbio.com/portfolio/hbv-assets.php

[Royal36]

Thank you Stephen hope they will come up with some thing encouraging.

[StephenCastlecrag]

Tetralogic will present their only HBV drug candidate, Birinapant.

[sorte]

Tetralogic is going to give some presentations there as well. Not sure what they want to show, nothing mentioned about birinapant.

http://www.marketwatch.com/story/tetralogic-to-present-at-the-jefferies-2015-hepatitis-b-summit-2015-07-29

TetraLogic Pharmaceuticals Corporation TLOG, +1.64% today announced that the Company will present at the Jefferies 2015 Hepatitis B Summit on Thursday, August 6, 2015 at 1:45 p.m. Eastern Time at the Boston Harbor Hotel. J. Kevin Buchi, CEO, will provide an overview of the Company, the Hepatitis B program and its corporate activities.

[twinboys1girl4me]

I understand why Replicor is working towards HBV+ HDV but wonder when/if they are going to trial HBV only.  I haven't been able to find any news on HBV only.  Am I missing something?